alanyl-glutamyl-aspartyl-glycine has been researched along with nickel in 1 studies
| Studies (alanyl-glutamyl-aspartyl-glycine) | Trials (alanyl-glutamyl-aspartyl-glycine) | Recent Studies (post-2010) (alanyl-glutamyl-aspartyl-glycine) | Studies (nickel) | Trials (nickel) | Recent Studies (post-2010) (nickel) |
|---|---|---|---|---|---|
| 181 | 8 | 28 | 24,777 | 382 | 9,504 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buadze, T; Gaiozishvili, M; Jokhadze, T; Lezhava, T; Monaselidze, J; Nemsadze, G | 1 |
1 other study(ies) available for alanyl-glutamyl-aspartyl-glycine and nickel
| Article | Year |
|---|---|
[GENOMIC VARIABILITY IN PATIENTS WITH DUCTAL FORM OF BREAST CANCER AND THE POSSIBILITY OF CORRECTION THE PEPTIDE BIOREGULATOR AND METAL IONS].
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Cations, Divalent; Chromatin; Chromosome Aberrations; Chromosome Fragile Sites; Drug Synergism; Female; Genetic Variation; Humans; Nickel; Oligopeptides; Tumor Cells, Cultured | 2017 |